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ABSTRACT
Objective To assess the effectiveness of supervised
exercisetherapycomparedwithusualcarewithrespectto
recovery, pain, and function in patients with
patellofemoral pain syndrome.
Design Open label randomised controlled trial.
Setting General practice and sport physician practice.
Participants Patients with a new episode of
patellofemoral pain syndrome recruited by their general
practitioner or sport physician.
Interventions The intervention group received a
standardised exercise programme for 6 weeks tailored to
individual performance and supervised by a physical
therapist, and were instructed to practise the tailored
exercises at home for 3 months. The control group were
assigned usual care, which comprised a “wait and see”
approach of rest during periods of pain and refraining
from pain provoking activities. Both the intervention
group and the control group received written information
about patellofemoral pain syndrome and general
instructions for home exercises.
Main outcome measures The primary outcomes were self
reported recovery (7 point Likert scale), pain at rest and
pain on activity (0-10 point numerical rating scale), and
function (0-100 point Kujala patellofemoral score) at
3 months and 12 months follow-up.
Results A total of 131 participants were included in the
study: 65 in the intervention group and 66 in the control
group. After 3 months, the intervention group showed
better outcomes than the control group with regard to
pain at rest (adjusted difference −1.07, 95% confidence
interval −1.92 to −0.22; effect size 0.47), pain on activity
(−1.00, −1.91to −0.08;0.45),andfunction(4.92, 0.14to
9.72; 0.34). At 12 months, the intervention group
continued to show better outcomes than the control
group with regard to pain (adjusted difference in pain at
rest −1.29, −2.16 to −0.42; effect size 0.56; pain on
activity −1.19, −2.22 to −0.16; effect size 0.54), but not
function (4.52, −0.73 to 9.76). A higher proportion of
patients in the exercise group than in the control group
reportedrecovery(41.9%v35.0%at3monthsand62.1%
v 50.8% at 12 months), although the differences in self
reported recovery between the two groups were not
statistically significant. Predefined subgroup analyses
revealed that patients recruited by sport physicians
(n=30) did not benefit from the intervention, whereas
those recruited by general practitioners (n=101) showed
significant and clinically relevant differences in pain and
function in favour of the intervention group.
Conclusion Supervised exercise therapy resulted in less
pain and better function at short term and long term
follow-up compared with usual care in patients with
patellofemoral pain syndrome in general practice.
Exercise therapy did not produce a significant difference
in the rate of self reported recovery.
Trial registration ISRCTN83938749.
INTRODUCTION
Patellofemoral pain syndrome can be defined as pain
around the patella that occurs during or after high
loaded flexion and extension of the knee.
1-3 The main
symptom is pain, and the condition generally pro-
gresses to impaired function. Physicians, especially
general practitioners (GPs) and sport physicians, are
frequently confronted with patients who have patello-
femoral painsyndrome.Althoughthereare noprecise
epidemiological data, an average GP practice in the
Netherlands reports about five or six new cases a
year.
4 In sport medicine practices, patellofemoral
painsyndromecomprisesupto25%ofallnewrunning
injuries.
56Women are more likely to be affected than
men.
7Painusuallystartsduringadolescencewhenpar-
ticipationinsportingactivitiesishigh,
7althoughsymp-
toms can occur over a prolonged period of time.
8
Extensive diagnostic investigations do not yield speci-
fic pathology.
There is no agreement concerning the aetiology of
patellofemoralpainsyndromeorthemostappropriate
treatment. There is, however, general consensus that
the preferred treatment approach is non-surgical.
Rest during periods of pain and refraining from pain
provoking activities are advised; this “wait and see”
approachisadvocatedintheDutchnationalGPguide-
lines and is considered usual care.
9
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syndrome has been advocated since the 1990s. Strate-
gies range from simple quadriceps strengthening to
more complex exercise therapy including taping or
bracing.
13681011 According to a systematic review on
the benefits of exercise therapy for patellofemoral pain
syndrome,
12 there is only limited evidence that exercise
is more effective than no exercise with respect to pain
reduction. Furthermore, the evidence as to whether
exerciseprovidesfunctionalimprovementisconflicting.
The objective of the present study was to investigate
intheshorttermaswellasinthelongtermtheeffectsof
exercise therapy compared with usual care in patients
with patellofemoral pain syndrome.
METHODS
The study protocol has been published previously.
13
Briefly,patientsagedbetween14and40yearsconsult-
ing their GP or sport physician for patellofemoral pain
syndrome were eligible for this trial. Inclusion criteria
comprised the presence of at least three of the follow-
ing symptoms: pain when walking up or down stairs;
pain when squatting; pain when running; pain when
cycling; pain when sitting with knees flexed for a pro-
longed period of time; grinding of the patella; and a
positive clinical patellar test (such as Clarke’s test or
patellar femoral grinding test).
1415 Symptoms had to
have persisted for longer than 2 months but not longer
than 2 years. Patients were excluded if they had knee
osteoarthritis, patellar tendinopathy, Osgood-Schlatter
disease, or other defined pathological conditions of the
knee, or had previous knee injuries or surgery. Patients
werealsoexcludediftheyhadalreadybeentreatedwith
supervised exercise therapy.
Recruitmenttookplacein38“HONEUR”practices
—generalpracticesalliedwiththeDepartmentofGen-
eral Practice at Erasmus University Medical Centre—
and in four sports medical centres in Rotterdam,
Leidschendam, Breda, and Gorinchem. Eligible
patientswereinformedaboutthestudyandintroduced
totheresearchteam,whoprovidedpatientswithmore
extensive information, checked that patients met the
inclusion and exclusion criteria, and obtained
informed consent.
After inclusion, patients were randomly allocated to
theintervention(exercisetherapy)orthecontrol(usual
care).Therandomisationwasdonebyanindependent
researcher who used a computer generated list in
which patients were stratified by age (14-17 years or
18 years and older) and by recruiting physician (GP
or sport physician). A block size of eight was used
within the four strata.
Interventions
Patients in the intervention group followed a standar-
dised exercise protocol tailored to individual achieve-
ment and were supervised by a physical therapist. The
programme consisted of a general warm up on a
bicycle ergometer followed by static and dynamic
muscular exercises for the quadriceps, adductor, and
glutealmuscles.Theprogrammealsoincludedbalance
exercises and flexibility exercises for major thigh mus-
cles. Patients exercised for 25 minutes supervised by
the physical therapist. The load of the exercise pro-
gramme was increased every 2 weeks during the first
6 weeks by increasing the number of repetitions or the
intensity of the exercises.
The increment of the exercise protocol was moni-
tored by the physical therapist who was guided by
painreactiononexertion.Patients visitedthe therapist
ninetimesin6weeks.Inaddition,theywereinstructed
to practise the exercises daily for 25 minutes over a
period of 3 months. To enhance compliance, patients
received a tutorial with photographs, a text explaining
the exercises, and a diary to register the amount of
exercising.
Both the intervention group and the control group
received standardised information and advice from
their GP or sport physician about the background of
patellofemoral pain syndrome and its good prognosis,
aswell asadvice torefrainfrom all sportsactivitiesthat
provoke pain. Patients were recommended to use a
simple analgesic such as paracetamol when pain was
severe and to find alternative ways to keep in shape.
Instructionsfordailyisometricquadricepscontractions
were given to both groups according to the guidelines
for Dutch GPs.
9 All this information was compiled to a
leafletthatwashandedtothepatientsinbothgroupsto
promote standardisation (see web extra).
Other interventions—like the use of bandages or
braces, insoles, or ice applications, or consumption of
medicationotherthansimpleanalgesics—wereallowed
in both groups. Information about these additional
interventions was collected after 6 weeks and at 3, 6, 9,
and 12 months using self report questionnaires. Physi-
cians were instructed not to refer patients in the control
grouptoaphysicaltherapistduringthefirst3monthsof
follow-up (that is, when participants in the intervention
groupwerereceivingtheexercisetherapy),andpatients
inthe controlgroupwereinstructednot tovisita physi-
cal therapist during this period.
Outcome measurement
Follow-up self report questionnaires were filled in by
patients at baseline, at 6 weeks, and at 3 months,
6 months, 9 months, and 12 months after inclusion in
the study. Primary outcomes measured at 3 and
12 months follow-up were: perceived recovery com-
pared with at the start of the study, measured on a 7
point Likert scale ranging from “completely recov-
ered” to “worse than ever”; functional disability, mea-
sured using the Kujala Patellofemoral Scale, a disease
specific validated disability scale ranging from 0 (com-
plete disability) to 100 (fully functional)
16; and pain
severity at rest and on activity, measured using a
numerical rating scale ranging from 0 (no pain) to 10
(unbearable pain).
1718
Patientsweredeemedtohaverecoverediftheyrated
themselves as “fully recovered” or “strongly recov-
ered” on the Likert scale, whereas those who rated
themselves as “slightly recovered” to “worse than
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old was used to dichotomise perceived recovery into
twoclearcategories:“recovered”and“notrecovered.”
Sample size
Our sample size calculation was based on a previous
study by Clark et al that undertook a similar compar-
ison of interventions.
19 They reported an absolute
increase in recovery after one year of 22% in the exer-
cise therapy group (19% recovery in the usual care
group compared with 41% recovery in the exercise
therapy group). Such a difference can be detected sta-
tistically with 61 patients in each group (power 0.80,
alpha 0.05, one sided test for the additional value of
supervised exercise therapy). We anticipated that we
would need a study population of 136 patients, allow-
ing for a potential dropout rate of 10%.
Statistical analysis
Differences between the intervention and control
groupwereanalysedonanintentiontotreatbasis.Sub-
group analysis was performed for predefined sub-
groups based on age and type of recruiting physician.
Differences in dichotomous outcomes (between
“recovered” patients and “not recovered” patients)
were analysed using logistic regression techniques for
repeated measurements (including measurements at
6 weeks and at 3, 6, 9, and 12 months) and expressed
in odds ratios. Differences in continuous outcomes
(pain scores and functional scores) were analysed
with linear regression techniques for repeated mea-
surements,whichtakethecorrelationofmultiplemea-
surements within one patient into account.
Possible prognostic variables (age, gender, BMI,
duration of knee symptoms, presence of bilateral
symptoms, educational level, work participation,
sports participation, and recruiting physician) were
tested for their prognostic value in univariate regres-
sion analyses. All analyses were adjusted for baseline
values and for possible prognostic factors.
The influence of exercise therapy on each outcome
wastestedusingamodelthatincludedprognosticvari-
ableswithaPvalueof0.1orlessandbaselinevaluesfor
pain at rest, pain on activity, and function score.
Although the sample size calculation was based on a
one sided testing approach, for the convenience of
the reader we chose to show the results for the more
conservative two sided tests, which were statistically
significant at a P value of 0.05. For statistically signifi-
cant dichotomous outcomes, the number needed to
treat is given (defined as 1/risk difference for the
defined outcome). For continuous data, we report
effectsizes(Cohen’sd),whicharedefinedasthediffer-
ence in outcome between the groups divided by the
standard deviation of the baseline scores for this
outcome.
20 Differences in the number of additional
interventions used in both groups were tested with
Chi square statistics at a significance level of P=0.05.
Analyses were conducted with SPPS 12.0 (SPSS;
Chicago, IL, USA) and SAS 8.2 (SAS Institute; Cary,
NC, USA).
RESULTS
Between April 2005 and April 2007, 163 patients with
patellofemoral pain syndrome were recruited by the
participating GPs and sport physicians. Of these indi-
viduals, 16 patients did not meet the inclusion criteria,
10withdrewconsentafterbeinginformedmoreexten-
sively, and six were excluded because their symptoms
haddiminished.Therefore,atotalof131patientswere
enrolled in the study and randomly assigned to the
intervention group or the control group.
Figure 1 shows the recruitment, inclusion, assign-
ment, and subsequent follow-up of the study patients.
Theexercisetherapygroup(n=65)andcontrolgroup
(n=66) had similar baseline characteristics (table 1).
Almost twice as many women as men were included
in the whole sample. Bilateral knee symptoms were
Patients recruited by general practitioners and sports physicians (n=163)
Patients randomly assigned (n=131)
Exercise therapy (n=65) Control (n=66)
Additional interventions used (3 months):
  NSAIDs (n=4)
  Topical agents (n=2)
  Bandages/braces (n=13)
  Insoles (n=9)
  Physical therapy (n=0
#)
Additional interventions used (3 months):
  NSAIDs (n=10)
  Topical agents (n=8)
  Bandages/braces (n=20)
  Insoles (n=7)
  Physical therapy (n=8
#)
Analysed at 3 months
  Analysed for recovery (n=64)
  Analysed for function and for pain (n=65) 
Analysed at 3 months
  Analysed for recovery (n=62)
  Analysed for function and for pain (n=66) 
Additional interventions used (12 months):
  NSAIDs (n=2)
  Topical agents (n=2)
  Bandages/braces (n=5)
  Insoles (n=0)
  Physical therapy (n=13#)
Excluded (n=32):
  Did not meet inclusion criteria (n=16)
  No final informed consent (n=10)
  Symptoms diminished (n=6)
Violated protocol (n=8)
Received physical therapy
Violated protocol (n=6)
Did not visit the physical therapist
Lost to follow-up at 3 months (n=4):
  Lacked motivation (n=2 at 6 weeks
    and n=1 at 3 months)
  Moved abroad (n=1 at 6 weeks)
Lost to follow-up at 3 months (n=2):
  Lacked motivation (n=1 at 6 weeks)
  Unreachable (n=1 at 3 months)
Analysed at 12 months
  Analysed for recovery (n=64)
  Analysed for function and for pain (n=65) 
Analysed at 12 months
  Analysed for recovery (n=63)
  Analysed for function and for pain (n=66) 
Lost to follow-up at 12 months (n=3)
  Lacked motivation (n=1 at 6 months) 
  Moved (n=1 at 9 months) 
  Unreachable (n=1 at 12 months)
Lost to follow-up at 12 months (n=5)
  Poor communication/unreachable
  (n=2 at 6 months)
  Unreachable (n=1 at 9 months and
  n=2 at 12 months)
Additional interventions used (12 months):
  NSAIDs (n=5)
  Topical agents (n=3)
  Bandages/braces (n=8)
  Insoles (n=6)
  Physical therapy (n=8#)
Fig 1 | Flow chart of the recruitment, inclusion, assignment, and subsequent follow-up of the
study patients. #=physical therapy additional to intervention
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population had a high level of sports participation.
Primary outcome parameters
Tables 2 and 3 show the primary outcome measure-
ments (recovery, function scores, and pain) at baseline
and at 3 and 12 months follow-up. Outcomes at 3 and
12 months were missing for some patients, but avail-
able data from other time points were included in the
analyses. This approach meant that the number of
patientswasnotalwaysequalforthedifferentoutcome
measures.
Boththeinterventionandcontrolgrouphadalower
pain score at 3 months follow-up than at baseline. The
adjusted analysis at 3 months showed a significant dif-
ference in pain at rest (−1.07, 95% CI −1.92 to −0.22;
P=0.01) and pain on activity (−1.00, −1.91 to −0.08;
P=0.03) in favour of the exercise group. The function
score was considerably higher in the exercise than in
the control group (adjusted difference 4.92, 0.14 to
9.72; P=0.04). Effect sizes for exercise therapy ranged
from 0.47 (pain at rest) and 0.45 (pain on activity) to
0.34 (function).
There was no significant difference in self reported
recovery, as defined by the outcome measurement
“recovered,” between the groups at 3 months. When
we used the outcome measurement “improved” (that
is,“fully recovered,”“stronglyrecovered,”or “slightly
recovered”), however, we found that recovery at
3 months was significantly more likely in the exercise
group than in the control group (81% improved v 53%
improved; adjusted odds ratio 4.07, 95% CI 1.86 to
8.90; number needed to treat 3.6).
Between 3 and 12 months, another eight patients
were lost to follow-up (five in the intervention group
and three in the control group; see fig 1). One person
whowaslostbeforethe3monthfollow-upwaslocated
and available for follow-up in the 3-12 month period.
At the 12 monthfollow-up,furtherimprovementon
pain and function scores from baseline was noted for
both groups. The adjusted differences in pain scores
betweenthegroupsstillshowedasignificantdifference
in favourof the exercisegroup (painat rest −1.29, 95%
CI −2.16 to −0.42; P<0.01 and pain on activity −1.19,
−2.22 to −0.16; P=0.02). The effect sizes for exercise
therapy on pain were 0.56 and 0.54, respectively. The
difference in function scores at 12 months, however,
did not reach statistical significance (4.52, 95% CI
−0.73 to 9.76; P=0.09). The different between the two
groups in the proportion of patients reporting “recov-
ery” at 12 months was not significant.
Additionalanalysisof the data excludingthe partici-
pants who violated the protocol during the first
3 months of follow-up showed greater differences in
the outcome parameters of pain and function at 3 and
12 months. The odds ratio for the outcome parameter
“recovery” at 12 months increased from 1.60 to 2.10
(95% CI 0.94 to 4.66; P=0.07).
Subgroup analysis
Tables 4 and 5 present data for the subgroup analysis
byrecruitingphysician.Amongpatientsrecruitedbya
GP,thoseintheexercisegrouphadsignificantlyhigher
andclinicallyrelevantdifferencesonthepainandfunc-
tional outcome parameters compared with the control
group at both 3 and 12 months follow-up (effect size
pain at rest 0.67 (P<0.01) at 3 months and 0.79
(P<0.01) at 12 months; effect size pain on activity
0.62 (P<0.01) and 0.65 (P=0.02); and effect size func-
tion 0.57(P<0.01)and 0.55(P<0.01)).Amongpatients
recruited by a sport physician, however, those in the
exercise group did not show better outcomes than
Table 1 |Baseline characteristics of the study population
Exercisetherapy
(n=65)
Control
(n=66)
Total
(n=131)
Age in years (mean (SD)) 24.7 (8.6) 23.3 (7.8) 24.0 (8.2)
Age ≥18 years (%) 69.3 69.7 69.5
Male gender (%) 35.4 36.4 35.9
BMI (mean (SD)) 23.2 (3.9) 23.0 (3.4) 23.1 (3.6)
Duration of symptoms
2-6 months (%) 69.2 66.6 67.9
6-24 months (%) 31.8 33.4 32.1
Bilateral knee symptoms (%) 55.4 65.2 60.3
Educational level
Low (elementaryschool,lowerlevelhighschool)(%) 23.4 22.7 23.6
Medium or high (upper level high school, vocational
college, university) (%)
76.6 77.3 76.4
Hours of work a week
None (%) 26.2 28.8 27.4
<25 hrs (%) 35.4 36.4 35.9
≥25 hrs (%) 38.5 34.8 36.6
Sports participation (%) 75.4 75.8 75.6
Recruiting physician
General practitioner (%) 76.9 77.3 77.1
Sport physician (%) 23.1 22.7 22.9
Function score out of 100 (mean (SD)) 64.4 (13.9) 65.9 (15.2) 65.1 (14.5)
Pain at rest out of 10 (mean (SD)) 4.14 (2.3) 4.03 (2.3) 4.08 (2.3)
Pain on activity out of 10 (mean (SD)) 6.32 (2.2) 5.97 (2.3) 6.15 (2.2)
BMI, body mass index; SD, standard deviation.
Table 2 |Recovery at 3 and 12 months follow-up
Exercise therapy
(n=65)
Control
(n=66)
Adjusted odds
ratio† (95% CI) at
3 months
Adjusted odds
ratio† (95% CI) at
12 months Baseline 3months(n/N(%)) 12 months (n/N (%)) Baseline 3months(n/N(%)) 12 months (n/N (%))
Recovered* — 26/62 (41.9) 36/58 (62.1) — 21/60 (35.0) 30/59 (50.8) 1.34 (0.65 to 2.79) 1.60 (0.77 to 3.34)
Frequencies are reported for those patients available at that time point. Adjusted odds ratios are reported for the total available in analysis.
*Recovered=fully or strongly recovered.
†Recovery was adjusted for duration of symptoms.
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Still no significant differences were found between
the treatment and intervention groups for recovery at
3 and 12 months.
Afurthersubgroupanalysiswasdoneonthebasisof
age. The effect estimates for recovery, pain, and func-
tion at 3 and 12 months for patients aged 14-17 years
and for those aged 18 years or older were similar to
those in the whole cohort. Because of lower power,
therewere nosignificantdifferencesbetweenthe exer-
cise therapy and control groups according to age,
except for pain on activity at 3 months and pain at
rest at 12 months in patients aged 18 years or older.
Additional interventions
There was no significant difference between the inter-
vention group and the control group in the self
reported total amount of additional interventions
used (non-steroidal anti-inflammatory drugs
(NSAIDs), bandages/braces, insoles, oral medication,
and topical agents) during the first 3 months (that is,
when participants in the intervention group were
receiving the tailored exercise therapy). The use of
oral NSAIDs and topical agents in the control group,
however,wastwotofourtimeshigherthanintheinter-
vention group (P=0.096 and P=0.051, respectively;
fig 1).
Analysis of interventions used during the following
9 months (up to 12 months follow-up) showed similar
disparities between the two groups in additional inter-
ventionuse.TheselfreporteduseofNSAIDsandtopi-
cal agents was about three times higher in the control
group than in the intervention group (P=0.059 and
P=0.09, respectively), whereas the use of supportive
aids (bandages/braces) was about two times higher in
the control group (P=0.09).
DISCUSSION
In patients with patellofemoral pain syndrome, exer-
cisetherapyproducesbetterresultsregardingpainand
functionat 3monthsand at12monthsthanusualcare.
We did not find a significant difference between the
exercise therapy group and the control group in self
reported “recovery” (that is, patients who designated
themselves as “fully recovered” or “strongly recov-
ered”) at either 3 months or 12 months. Recovery at
3 months was significantly more likely in the exercise
group than in the control group when we used the out-
come measurement “improved” (that is, “fully recov-
ered,”“ strongly recovered,” or “slightly recovered”).
After 12 months, nearly all patients had improved,
and the difference between the groups was no longer
significant.
We therefore conclude that, although exercise ther-
apy is effective for improving pain and function, these
benefits are not clearly reflected in patients’ self
reported recovery. Although perceived recovery is
relevant as a clinical outcome, understanding what
exactly comprises recovery from the patient’s point
of view is difficult.
We suspected that external factors might influence
prognosis and possibly also effectiveness, so we strati-
fied our analysis for age and type of recruiting physi-
cian. Clinically relevant and statistically significant
effects of exercise on pain and function were found in
patients recruited by the GP. This subgroup was rela-
tively large (n=101) and contributed considerably to
the overall results. The group recruited by the sport
Table 3 |Function and pain scores at 3 and 12 months follow-up
Exercise therapy
(n=65)
Control
(n=66)
Adjusted difference*
(95% CI) at 3 months
Adjusted difference*
(95% CI) at 12 months
Baseline
(mean (SD))
3 months
(mean (SD))
12 months
(mean (SD))
Baseline
(mean (SD))
3 months
(mean (SD))
12 months
(mean (SD))
Function score (0-100) 64.4 (13.9) 78.8 (15.5) 83.2 (14.8) 65.9 (15.2) 74.9 (17.6) 79.8 (17.5) 4.92 (0.14 to 9.72) 4.52 (−0.73 to 9.76)
Pain at rest (0-10) 4.14 (2.3) 2.30 (2.5) 1.43 (2.2) 4.03 (2.3) 3.22 (2.8) 2.61 (2.9) −1.07 (−1.92 to −0.22) −1.29 (−2.16 to −0.42)
Pain on activity (0-10) 6.32 (2.2) 3.81 (2.9) 2.57 (2.9) 5.97 (2.3) 4.60 (3.0) 3.54 (3.38) −1.00 (−1.91 to −0.08) −1.19 (−2.22 to −0.16)
Mean scores are reported for those patients available at that time point. Adjusted differences are reported for the total available in analysis.
*Function score was adjusted for baseline score, age, and duration of symptoms. Pain at rest was adjusted for baseline score and age. Pain on activity was adjusted for baseline score, age,
and gender. Positive adjusted differences for the function score, and negative difference for pain scores, are in favour of the exercise group.
Table 4 |Recovery at 3 and 12 months follow-up for patients recruited by a general practitioner compared with those
recruited by a sport physician
Exercise therapy
(n=50)
Control
(n=51) Adjusted odds
ratio† (95% CI) at
3 months
Adjusted odds
ratio† (95% CI) at
12 months Baseline
3 months
(n/N (%))
12 months
(n/N (%)) Baseline
3 months
(n/N (%))
12 months
(n/N (%))
Patients recruited by general practitioners
Recovered* — 22/48 (45.8) 28/44 (63.4) — 14/46 (30.4) 22/45 (48.8) 2.10 (0.89 to 4.93) 1.95 (0.82 to 4.65)
Patients recruited by sport physicians
Recovered* — 4/14 (28.6) 8/14 (57.1) — 7/14 (50.0) 8/14 (57.1) 0.39 (0.08 to 1.83) 0.97 (0.22 to 4.25)
Frequencies are reported for those patients available at that time point. Adjusted odds ratios are reported for the total available in analysis.
*Recovered=fully or strongly recovered.
†Recovery was adjusted for duration of symptoms.
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any effect of exercise therapy compared with usual
care. The confidence intervals for this analysis were
wide, so coincidental findings owing to the small num-
bersofpatientsrecruitedbysportphysicianscannotbe
excluded. There were no possible explanatory differ-
ences in baseline characteristics (including frequency
and duration of symptoms, sports participation, and
BMI) between patients recruited by a GP and those
recruited by a sport physician.
There was no difference between the exercise ther-
apygroupandthecontrolgroupinthenumberofaddi-
tional interventions used during the first 3 months of
the study, although there was a two-fold to three-fold
higher use of NSAIDs and a four times higher use of
topical agents in the control group. These figures
remained stable during the course of one year. These
additional interventions might have influenced the
outcome measurements. The use of additional inter-
ventions was higher in the control group, however,
implying that differences in outcome measurements
between the groups are more likely to be underesti-
mated than overestimated. Although not significant,
thehigheruseofadditionalinterventionsinthecontrol
group may indicate a trend towards greater use of self
supportivemeansbypatientswithpatellofemoralpain
syndrome not referred to an exercise programme.
When considered alongside the better outcome on
pain scores in the exercise group, the data indicate
that the control group had an objective need to use
pain medication.
Comparison with other studies
Various studies have evaluated the efficacy of exercise
therapy for patellofemoral pain syndrome. Early stu-
dies without a control group indicated that rehabilita-
tion including exercise therapy could be beneficial for
patients with patellofemoral pain syndrome.
2122
Witvrouw et al studied the effect of open compared
with closed chain exercises in patients with patellofe-
moral pain syndrome.
2324 Both types of exercise led to
an improvement in pain scores and an increase in
strengthofthequadricepsandhamstrings.Theauthors
stated that, as a result of their study, they would use
both open and closed kinetic chain exercises in the
non-operative treatment protocol for patients with
patellofemoralpain.
2324Giventhesefindings,bothiso-
metric/concentricandeccentricexerciseswereusedin
thepresentstudy.Patientswerealsoallowedtopractise
in an open and closed kinetic chain position.
Various other studies have evaluated the efficacy of
exercise therapy for patellofemoral pain syndrome.
Systematic reviews, however, have reported that
most of these studies are of poor methodological qual-
ity in that they lack randomisation, a control group, or
clearly defined outcome parameters.
1225
To our knowledge, six randomised studies, includ-
ing our own study, have compared exercise therapy
with non-exercise therapy. One low quality study
foundthataspecialbracedesignedtoprovideprogres-
sive resistance exercise during activities of daily living
improved function and pain,
26 whereas another study
found no significant differences in outcomes between
patientsonahomeexerciseprogrammeandthosewith
a patellar brace.
27
Additionally, three trials studied the effects of
physiotherapy (including exercise therapy) compared
with other treatment or placebo treatment.
192829The
small study by Crossley et al compared the effect of a
6 week programme of exercise therapy plus taping,
mobilisation techniques, and biofeedback with a pla-
cebo therapy (sham ultrasound, placebo taping, and
application of non-therapeutic gel).
28 After 6 weeks,
the multimodal physiotherapy group showed a signifi-
cant decrease in worst pain, usual pain, and anterior
knee pain compared with the placebo group. The
recent study by Collins et al compared the use of
insoles (flator prefabricated) with 6 weeksof multimo-
dalphysiotherapy(includingexercises).
29At6,12,and
52 weeks, no differences were found between groups
regarding pain, function, and recovery.
These studies, however, do not answer the question
ofwhethertheeffectofsupervisedexercisesisadditive
to usual care, as was tested in our study. In the small
Table 5 |Function and pain scores at 3 and 12 months follow-up for patients recruited by a general practitioner compared with those recruited by a sport
physician
Exercise therapy
(n=50)
Control
(n=51)
Adjusted difference*
(95% CI) at 3 months
Adjusted difference*
(95% CI) at 12 months
Baseline
(mean (SD))
3 months
(mean (SD))
12 months
(mean (SD))
Baseline
(mean (SD))
3 months
(mean (SD))
12 months
(mean (SD))
Patients recruited by general practitioners
Function score (0-100) 63.9 (14.0) 79.2 (15.5) 84.7 (13.2) 66.6 (14.8) 73.4 (17.8) 78.6 (18.3) 8.23 (3.18 to 13.28) 7.90 (2.20 to 13.60)
Pain at rest (0-10) 4.50 (2.3) 2.22 (2.3) 1.23 (2.0) 4.18 (2.4) 3.50 (2.8) 2.82 (3.1) −1.56 (−2.52 to −0.61) −1.82 (−2.82 to −0.82)
Pain on activity (0-10) 6.44 (2.2) 3.78 (2.8) 2.45 (2.6) 5.98 (2.4) 4.91 (2.9) 3.64 (3.5) −1.42 (−0.39 to −2.45) −1.49 (−0.29 to −2.69)
Patients recruited by sports physicians
Function score (0-100) 65.8 (14.0) 77.5 (16.4) 78.4 (18.6) 63.6 (16.6) 79.6 (16.7) 83.9 (14.7) −4.11 (−15.54 to 7.33) −5.31 (−17.24 to 6.62)
Pain at rest (0-10) 2.93 (2.1) 2.57 (3.3) 2.07 (2.7) 3.53 (1.9) 2.29 (2.5) 1.93 (2.2) 0.77 (−1.15 to 2.69) 0.56 (−1.15 to 2.28)
Pain on activity (0-10) 5.93 (1.9) 3.93 (3.4) 2.93 (3.5) 5.93 (2.0) 3.57 (3.0) 3.21 (3.0) 0.41 (−1.83 to 2.64) −0.21 (−2.49 to 2.06)
Mean scores are reported for those patients available at that time point. Adjusted differences are reported for the total available in analysis.
*Function score was adjusted for baseline score, age, and duration of symptoms. Pain at rest was adjusted for baseline score and age. Pain on activity was adjusted for baseline score, age,
and gender. Positive adjusted differences for the function score, and negative difference for pain scores, are in favour of the exercise group.
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19 exercise, taping, and education
were compared with exercise and education, taping
and education, and education alone. Exercise was not
significantly better than non-exercise for pain and
function after 3 months. At 12 months, however, pain
scores were significantly better for the exercise group.
A high proportion of patients (approximately 40%)
waslosttofollow-upat12monthsinthisstudythough,
which could have influenced these results.
Strengths and limitations of study
A methodological problem that cannot be solved in
randomised controlled trials of exercise therapy is
that patients in the intervention group cannot be
blinded for the exercise therapy and, therefore, may
be biased for positive outcome (placebo effect). To
overcome this problem in part, a blinded external
observercouldbeusedtoprovideobjectiveandobser-
vationalmeasures offunctionaloutcomes.Someinter-
vention studies on exercise therapy in patellofemoral
pain syndrome have used quantifiable measures for
muscle strength as an outcome. However, several
studies have shown that the relationship between
increase in muscle strength and clinical outcome is
inconsistent.
30-32 In addition, these studies clearly illus-
trate the difficulty of interpreting the effect of therapy
usingmuscle strengthasan outcomemeasure for knee
function.Therefore,asnovalidatedobjectiveoutcome
measures for patellofemoral pain syndrome are cur-
rently available, the use of validated subjective out-
come measures seems appropriate.
Along with the observed effect of exercise therapy,
the role of supervision and attention of a physical
therapist as well as the use of an exercise diary may
have influenced the outcome in the intervention
group. The attention from the physical therapist is an
integral part of the supervised exercise therapy inter-
vention.Ontheotherhand,theuseofanexercisediary
in the intervention group to assess compliance may
have caused a bias owing to awareness of being
involved in a study (Hawthorne effect).
33
In addition, our control group was allowed to do
single isometric quadriceps contractions and is, there-
fore, not a real non-exercise group. This resembles the
usualcare(“waitandsee”approach)prescribedbyGPs
in the Netherlands according to national guidelines.
9
We thus studied the additional value of supervised
exercise therapy but not the effect of doing exercises,
whichmighthavediminishedthecontrastbetweenthe
groups. Although we noted that eight patients in the
control group received physical therapy (that is, they
violated the protocol), we do not know to what extent
this physical therapy resembled the standardised
supervised exercise therapy in the intervention
group. Therefore, an analysis by protocol by compar-
ingphysicaltherapywithnophysicaltherapydoesnot
seem appropriate.
The differences between the intervention group and
thecontrolgroupwerefurtherdiminishedbyviolation
of the protocol by 14 people: 6 people in the inter-
vention group did not visit the physical therapist and
subsequently did not receive the supervised exercise
therapy, and eight people in the control group visited
a therapist and received physical therapy although
they were instructed not to. Additional analysis of the
dataexcludingtheparticipantswhoviolatedtheproto-
col during the first 3 months of follow-up showed
greater differences in the outcome parameters on
pain and function at 3 and 12 months. This change
indicates that the effects of exercise therapy may
indeed be even higher than those reported in our pri-
mary analysis.
A final remark can be made about the diagnosis of
patellofemoralpainsyndrome.Patientswererecruited
by GPs and sport physicians who were offered a set of
inclusion and exclusion criteria, some of which were
related to physical examination. The researchers did
not supervise the physicians in their judgment of diag-
nosis.Nevertheless,wethinkthatthisapproachreflects
common practice and therefore increased the clinical
applicability of our results.
Conclusions
This study provides evidence that supervised exercise
therapy for patellofemoral pain syndrome in general
practice is more effective than usual care” for the out-
comeparameterspainatrest,painonactivity,andfunc-
tion at 3 and 12 months. However, supervised exercise
therapy had no effect on perceived recovery. Further
research should aim to elucidate the mechanisms
whereby exercise therapy results in better outcome.
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